Loading…

Cerium oxide nanoparticles: In pursuit of liver protection against doxorubicin-induced injury in rats

[Display omitted] •Cerium nanoparticles did not detriment serum biochemistry/liver histology in rats.•Cerium nanoparticles mitigated doxorubicin-associated lipid peroxidation in rats.•Cerium nanoparticles protected rats against doxoruibicin-induced liver injury.•Ceria could be used as a prophylactic...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2018-07, Vol.103, p.773-781
Main Authors: Ibrahim, Heba G., Attia, Noha, Hashem, Fatma El Zahraa A., El Heneidy, Moushira A.R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Cerium nanoparticles did not detriment serum biochemistry/liver histology in rats.•Cerium nanoparticles mitigated doxorubicin-associated lipid peroxidation in rats.•Cerium nanoparticles protected rats against doxoruibicin-induced liver injury.•Ceria could be used as a prophylactic option for doxorubicin hepatic toxicity. Doxorubicin (DOX) is considered as a backbone in several chemotherapeutic regimens. Nevertheless, the reported systemic toxicity usually hampers its broad application. Interestingly, Cerium oxide nanoparticles (CeONPs) depicted promising regenerative antioxidant and hepatoprotective potentials against multiple oxidative stress-induced pathologies. Thus, the aim of the present study was to determine either CeONPs would display hepatoprotective properties once concomitantly administered with DOX or not. Male Sprague Dawley rats were divided into four groups (n = 10) in a two weeks study: Control (received saline, IP injection thrice a week), CeO (0.5 mg/kg, IP injection once a week), DOX (2.5 mg/kg, IP injections thrice a week) and DOX + CeO (received both treatments). Hepatic toxicity was assessed by histological and ultrastructural studies. In addition, serum transaminases (ALT, AST) and malondialdehyde (MDA), an oxidative stress marker, were evaluated. CeONPs were not only proved to be safe at the proposed dose, but also their concomitant administration with DOX managed to mitigate DOX-induced hepatic insult on both histological and biochemical aspects. Such hepatoprotective behavior was referred to the noticed antioxidant action CeONPs as highlighted by the significant difference in MDA levels.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2018.04.075